Logo
x

Search

Subscribe Now

alvotech

Alvotech Reports the Initiation of Confirmatory Trial of AVT16 (Biosimilar, Entyvio)

Alvotech Reports the Initiation of Confirmatory Trial of AVT16 (Biosimilar, Entyvio)

  • September 25, 2024
EMA Accepted the Marketing Application of Alvotech’s AVT06 a Biosimilar of Eylea (aflibercept)

EMA Accepted the Marketing Application of Alvotech’s AVT06 a Biosimilar of Eylea (aflibercept)

  • August 16, 2024
Alvotech Reports Data from Confirmatory Trial of AVT03 (Biosimilar, Prolia and Xgeva)

Alvotech Reports Data from Confirmatory Trial of AVT03 (Biosimilar, Prolia and Xgeva)

  • July 3, 2024
Alvotech and Advanz Pharma Team Up to Commercialize AVT06/AVT29 (Biosimilar, Eylea) in Europe

Alvotech and Advanz Pharma Team Up to Commercialize AVT06/AVT29 (Biosimilar, Eylea) in Europe

  • June 18, 2024
PharmaShots Weekly Snapshots (June 10 – June 14, 2024)

PharmaShots Weekly Snapshots (June 10 – June 14, 2024)

  • June 14, 2024
Alvotech and STADA Extend their Strategic Partnership Covering AVT03 (Biosimilar, Denosumab)

Alvotech and STADA Extend their Strategic Partnership Covering AVT03 (Biosimilar, Denosumab)

  • June 12, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.